The AminoLock® Collagen is produced using a unique technology developed by Genacol. This technology is PATENT PENDING.
Our mission is to offer all men and women concerned about their joint health the best
innovative products in terms of safety, quality and efficiency. Our three clinical studies, along with our patent pending technology, prove that our products are unique, innovative, different and efficient. Responding to our customers’ needs is our passion and continuous commitment. We are dedicated to the well-being of our customers through their joint health and healthy aging.
Our credo: To achieve excellence in harmony.
In the mid-1990s, a research and development company located on Montreal’s North Shore discovered the virtues of collagen hydrolyzate as a natural supplement to relieve joint pain. The highly advanced manufacturing methods of this formulation are based on high technological standards that strongly distinguish Genacol® products from other products.
In October 2000, Guy Michaud founded the DirectLab Laboratory Inc., now known as Corporation Genacol Canada Inc. It was also at this time that the first product, the original formula of Genacol, entered the market. Very quickly, the product was an indisputable success, so that only a few years later it became the leader of its category. Over the years, Genacol has received several important awards such as the recipient of the “Entrepreneur of the Year Ernst and Young” award in the “Health and Science” category as well as the first position in health in the magazine Profit 100 for its progression between 2004 and 2009.
Genacol took another step in June 2011 when the family business set up a new 17,000-square-foot construction in its new headquarters.
Genacol continues to innovate and offer new products to its customers. Now it is with 8 products that the Genacol range maintains its leading position in the category of joint health in Quebec. The company is also very proud of its international reputation with a presence in more than 40 countries.
Genacol’s Aminolock collagen has the lowest molecular weight in the world, providing superior absorption by the body. With three independent scientific studies demonstrating the beneficial effects of its proprietary Aminolock collagen, Genacol filed a patent application in Canada and the United States in early 2017.
Genacol now focuses on the international market, research and development of new innovative natural health products.
Genacol has been a leader in its field for more than 17 years. The company continues to innovate, with the goal of offering its customers effective, new products.
is proud to be the Consumer’s Choice winner for 5 consecutive years in the Joint Health Product category
3 Clinical studies confirm the effectiveness of Genacol products to reduce joint pain.
Genacol products are produced from a patented technology